Bob Tranchida - Mach7 Technologies Vice Marketing

M7T Stock

0.34 0.02 5.56%

Executive

Bob Tranchida is Vice Marketing of Mach7 Technologies

Address	120 Kimball Avenue, South Burlington, VT, United States, 05403
Phone	802 861 7745
Web	https://www.mach7t.com

Mach7 Technologies Management Efficiency

The company has return on total asset (ROA) of (0.0837) % which means that it has lost $0.0837 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1432) %, meaning that it generated substantial loss on money invested by shareholders. Mach7 Technologies' management efficiency ratios could be used to measure how well Mach7 Technologies manages its routine affairs as well as how well it operates its assets and liabilities. Liabilities And Stockholders Equity is likely to gain to about 76.7 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 1.9 M in 2024.

Compare Mach7 Technologies to Peers

Predict price of Mach7 Technologies

Mach7 Technologies has accumulated 1.27 M in total debt. Debt can assist Mach7 Technologies until it has trouble settling it off, either with new capital or with free cash flow. So, Mach7 Technologies' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Mach7 Technologies sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Mach7 to invest in growth at high rates of return. When we think about Mach7 Technologies' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives			EXECUTIVE Age
	Anthony Waldron	Rea Group	N/A
	Alexander Schirmeister	Xero	N/A
	Ashley Grech	Xero	N/A
	Kul Singh	Rea Group	N/A
	Dave Ross	CSL	N/A
	Dean Phizacklea	Cochlear	N/A
	Andy Schmeltz	CSL	53
	H Doran	Tamawood	N/A
	Kate Priestman	CSL	51
	John CPA	CSL	N/A
	Christina Hickie	CSL	N/A
	Jason Lee	Block Inc	N/A
	Sukhinder Cassidy	Xero	54
	Kate McLaughlin	Xero	N/A
	Nicole Mehalski	Xero	N/A
	Alyssa Henry	Block Inc	54
	MPH MD	CSL	65
	Roanne Parry	CSL	51
	Siobhan Lane	Light Wonder	42
	Richard Schneider	Light Wonder	66
	Robert Parente	Light Wonder	63

Mach7 Technologies (M7T) is traded on Australian Securities Exchange in Australia and employs 11 people. Mach7 Technologies is listed under Health Care Technology category by Fama And French industry classification.

Management Performance

	Return On Equity	-0.14
	Return On Asset	-0.0837

Mach7 Technologies Leadership Team

Elected by the shareholders, the Mach7 Technologies' board of directors comprises two types of representatives: Mach7 Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Mach7. The board's role is to monitor Mach7 Technologies' management team and ensure that shareholders' interests are well served. Mach7 Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Mach7 Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.

	Kelly Kimball, Vice Culture
	Bob Tranchida, Vice Marketing
	Michael Lampron, MD CEO
	Francoise Dixon, Head Relations
	Rebecca Thompson, Head Relations
	ACIS ACIS, Company Secretary
	Steven Parkes, Global Officer
	Dyan OHerne, Chief Officer
	David Madaffri, Chief Officer
	ACIS AGIA, Company Secretary
	Veronique MorganSmith, Company Sec

Mach7 Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Mach7 Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

	Return On Equity	-0.14
	Return On Asset	-0.0837
	Profit Margin	(0.27) %
	Operating Margin	(0.29) %
	Current Valuation	60.73 M
	Shares Outstanding	241.24 M
	Shares Owned By Insiders	27.00 %
	Shares Owned By Institutions	23.94 %
	Price To Book	1.58 X
	Price To Sales	2.90 X

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Mach7 Stock Analysis

When running Mach7 Technologies' price analysis, check to measure Mach7 Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mach7 Technologies is operating at the current time. Most of Mach7 Technologies' value examination focuses on studying past and present price action to predict the probability of Mach7 Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mach7 Technologies' price. Additionally, you may evaluate how the addition of Mach7 Technologies to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC